PR Newswire
PHILADELPHIA, June 10, 2022 /PRNewswire/ -- Berger Montague is investigating securities fraud allegations on behalf of investors who purchased the securities Dentsply Sirona, Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) between June 9, 2021 and May 9, 2022 (the "Class Period").
If you purchased the securities of Dentsply during the Class Period, would like to discuss Berger Montague's investigation, or have questions concerning your rights or interests, please contact attorneys Andrew Abramowitz at [email protected] or (215) 875-3015, or
Michael Dell 'Angelo at [email protected] or (215) 875-3080 or visit: https://investigations.bergermontague.com/dentsply-sirona/
Whistleblowers: Anyone with non-public information regarding Dentsply is encouraged to confidentially assist Berger Montague's investigation or take advantage of the SEC Whistleblower program. Under this program, whistleblowers who provide original information may receive rewards totaling up to thirty percent (30%) of recoveries obtained by the SEC. For more information, contact us.
Dentsply is a dental equipment manufacturer that produces a wide array of dental supplies, ranging from anesthetics, plaque and gum disease prevention, tooth polishers, and artificial teeth.
The complaint alleges that, throughout the Class Period, Defendants orchestrated a scheme to inflate the Company's revenue and earnings by manipulating its accounting for a distributor rebate program in order for senior...
Read Full Story:
https://www.gurufocus.com/news/1770972/dentsply-sirona-inc-company-news-berge...